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The lactose operon from 
Lactobacillus casei is involved in the 
transport and metabolism of the 
human milk oligosaccharide core-2 
N-acetyllactosamine
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The lactose operon (lacTEGF) from Lactobacillus casei strain BL23 has been previously studied. 
The lacT gene codes for a transcriptional antiterminator, lacE and lacF for the lactose-specific 
phosphoenolpyruvate: phosphotransferase system (PTSLac) EIICB and EIIA domains, respectively, and 
lacG for the phospho-β-galactosidase. In this work, we have shown that L. casei is able to metabolize 
N-acetyllactosamine (LacNAc), a disaccharide present at human milk and intestinal mucosa. The 
mutant strains BL153 (lacE) and BL155 (lacF) were defective in LacNAc utilization, indicating that the 
EIICB and EIIA of the PTSLac are involved in the uptake of LacNAc in addition to lactose. Inactivation of 
lacG abolishes the growth of L. casei in both disaccharides and analysis of LacG activity showed a high 
selectivity toward phosphorylated compounds, suggesting that LacG is necessary for the hydrolysis of 
the intracellular phosphorylated lactose and LacNAc. L. casei (lacAB) strain deficient in galactose-6P 
isomerase showed a growth rate in lactose (0.0293 ± 0.0014 h−1) and in LacNAc (0.0307 ± 0.0009 h−1) 
significantly lower than the wild-type (0.1010 ± 0.0006 h−1 and 0.0522 ± 0.0005 h−1, respectively), 
indicating that their galactose moiety is catabolized through the tagatose-6P pathway. Transcriptional 
analysis showed induction levels of the lac genes ranged from 130 to 320–fold in LacNAc and from 100 
to 200–fold in lactose, compared to cells growing in glucose.
All human milk oligosaccharides (HMOs) contain lactose (Galβ1-4Glc) at the reducing end, which can be elon-
gated with lacto-N-biose (LNB, type-1 core; Galβ1-3GlcNAc) by a β-1,3 bond and/or with N-acetyllactosamine 
(LacNAc, type-2 core; Galβ1-4GlcNAc) by a β-1,3 or β-1,6-bond1,2. Recently, LacNAc has also been found as a 
free disaccharide in human milk, with concentrations that decrease from 310 μg/ml on colostrum to 6.7 μg/m 
after the first week of lactation3. LacNAc is also a common structure of human glycans present at mucosal surfaces 
and other specific tissues and cells4. The LacNAc residues usually constitute the terminal sugars that form part 
of the variable portions of the glycan epitopes, including O-glycans, N-glycans and glycolipids. Sometimes these 
proteins and lipids carry poly-N-acetyllactosamines chains, which can be acceptors for subsequent glycosylations 
and serve as specific arms to present other functional terminal glycans4. Additionally, LacNAc is a constituent 
of the ABO and Lewis blood group antigens, which are expressed on the membrane of blood red cells and other 
tissues, including the gastrointestinal epithelium5.
The gastrointestinal tract of breast-fed infants is rapidly colonized by Bifidobacterium species6, which are 
well adapted to metabolize HMOs7. This capacity has been associated with a complete array of enzymes that 
includes various types of intra- and extracellular glycosidases8–10. LacNAc and other LacNAc-containing oli-
gosaccharides, such as lacto-N-neotetraose and lacto-N-hexaose, are digested in vitro by the extracellular 
membrane-bound β-galactosidase BbgIII cloned from Bifidobacterium bifidum11,12. This species also contains 
three intracellular β-glycosidases (BbgI, BbgII and BbgIV) able to hydrolyze LacNAc in vitro, although dif-
ferent from BgbIII, they have higher affinity for lactose than for LacNAc11,12. Galactose is also liberated from 
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the LacNAc contained in the lacto-N-neotetraose structure by β-galactosidases described in Bifidobacterium 
longum and Bifidobacterium breve strains13. The genus Lactobacillus has many characterized probiotic strains14,15 
and some species have also been isolated from the gastrointestinal tract of infants16,17. However, contrarily to 
Bifidobacterium species, genome analysis of lactobacilli revealed that they have a limited capability to ferment 
HMOs or mucosa-derived glycans18–20. One exception to this are the members of the Lactobacillus casei/para-
casei/rhamnosus phylogenetically close group. We have previously characterized in L. casei three genes encod-
ing α-L-fucosidases and purified the corresponding enzymes, which hydrolyze in vitro fucosylated HMOs21. 
Specifically, the operon alf, encoding the α-L-fucosidase AlfB, the transcriptional repressor AlfR and the EII 
components of a mannose-class phosphoenolpyruvate: phosphotransferase system (PTS), is involved in these 
species in the metabolism of fucosyl-α1,3-GlcNAc disaccharide, an structure present in HMOs and mucins22,23. 
The type-1 HMOs core LNB and the type-1 core O-glycosylation galacto-N-biose (GNB) are also metabolized 
by L. casei24. Both disaccharides are transported and phosphorylated by the PTSGnb and then are hydrolyzed by 
the phospho-β-galactosidase GnbG, which are encoded by the gnb operon24. Recently, we have characterized the 
cell-wall anchored N-acetylglucosaminidase BnaG necessary for the utilization of the trisaccharide lacto-N-triose 
by L. casei25. BnaG is the only extracellular glycosidase described until now for the metabolism of HMOs in lacto-
bacilli. L. casei also metabolizes lactose and the lac operon (Fig. 1a) from L. casei strain BL23 has been extensively 
studied in our laboratory26–29. The lacT gene codes for a transcriptional antiterminator, lacE and lacF genes for 
the lactose-specific PTS, EIICB and EIIA domains, respectively, and lacG for the phospho-β-galactosidase27. The 
lac operon is induced by lactose through transcription antitermination mediated by LacT28. Additionally, the 
expression of this operon is subject to carbon catabolite repression mediated by the general regulatory protein 
CcpA (catabolite control protein A) and also by PTS elements via LacT26,28. Despite the relevance of the LacNAc 
disaccharide, its metabolism has not been studied in the genus Lactobacillus. Here we report that L. casei strain 
BL23 is able to grow in the presence of LacNAc and that the lac operon is involved in its metabolism. Additionally, 
we demonstrated that the tagatose-6P pathway and the N-acetylglucosamine-6P deacetylase NagA are involved 
in the catabolism of this disaccharide.
Results
L. casei BL23 can be cultured in the presence of LacNAc and transports it by the PTSLac. We 
have previously shown that L. casei is able to transport and ferment LNB, the type-1 disaccharide building block 
of HMOs24. In order to determine the ability of this species to metabolize the type-2 core structure of HMOs, we 
cultured L. casei BL23 in sugar-free MRS supplemented with 4 mM LacNAc as carbon source (Fig. 2). The results 
showed that L. casei can grow in the presence of this disaccharide and that the maximum cell density reached is 
similar to that obtained in lactose, which was used as a positive control.
Most of the characterized PTS are specific for one carbohydrate, however some PTS can transport two or more 
structurally related sugars30–32. Therefore, we analyzed if LacNAc, which is structurally similar to LNB and lactose, 
Figure 1. (a) Genetic organization of the lac operon in Lactobacillus casei strain BL23. Hairpin loops 
indicate rho-independent transcriptional terminators. cre, catabolite responsive element; RAT, ribonucleic 
antiterminator; LacT is a transcriptional antiterminator; EIICB and EIIA, domains of the lactose-specific 
phosphoenolpyruvate: phosphotransferase system (PTSLac); LacG, phospho-β-galactosidase. (b) Schematic 
presentation of the pathways for N-acetyllactosamine (LacNAc) and lactose (Lac) transport and metabolism 
in L. casei BL23. GlcNAc: N-acetylglucosamine; Fru, fructose; DHAP: dyhidroxyacetone phosphate; GAP: 
glyceraldehyde 3-phosphate; PEP: phosphoenolpyruvate; NagA, N-acetylglucosamine-6P deacetylase; NagB: 
glucosamine-6P deaminase; Pfk: 6-phosphofructo-1-kinase; Gk, glucokinase; Pgi, phosphoglucose isomerase; 
LacAB: galactose-6P isomerase; LacC: tagatose-6P kinase; LacD: tagatose-1,6 P aldolase; Fba: fructose-1,6 P 
aldolase; Tpi: triose phosphate isomerase.
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is transported in L. casei BL23 by the PTSGnb or by the PTSLac, which are involved in LNB and lactose uptake, 
respectively24,28. The mutant strains BL385 (gnbC)24, that is disrupted in the gene encoding the EIIC domain of the 
PTSGnb, BL153 (lacE) and BL155 (lacF)28, which are impaired in the EIICB and EIIA, respectively, of the PTSLac, 
were tested for their capacity to ferment LacNAc. BL385 (gnbC) was able to grow in the presence of LacNAc as 
carbon source (Fig. 3a). Contrarily, strains BL153 (lacE) and BL155 (lacF) showed a poor growth with LacNAc 
which was similar to that of the negative controls (lactose supplemented and non-supplemented sugar-free MRS) 
(Fig. 3b,c). The growth pattern of strains BL153 (lacE) and BL155 (lacF) in the presence of glucose as a positive 
control is also shown (Fig. 3b,c). Analysis for sugar content in the supernatants demonstrated that LacNAc was 
consumed by strain BL385 (gnbC) but not by strains BL153 (lacE) and BL155 (lacF) (data not shown), indicating 
that the domains EIICB and EIIA encoded by lacE and lacF, respectively, are involved in the uptake of LacNAc 
(Fig. 1). It has been previously shown that the PTS from L. casei can accomplish sugar transport not coupled to 
phosphorylation23. Then, to further confirm the involvement of the PTSLac in the transport of LacNAc and to 
test if transport though the EII permease was coupled to phosphorylation, the growth pattern of BL126 (ptsI), 
a mutant lacking the PTS-general component Enzyme I33, was tested in LacNAc as carbon source. BL126 (ptsI) 
did not grow in the presence of LacNAc (Fig. 3d), confirming that its utilization needs a functional complete 
PTS. These results suggest that LacNAc is internalized as a phosphorylated derivative. BL126 (ptsI) was grown 
with glucose and lactose as positive and negative controls, respectively. The growth pattern of strain BL126 in the 
presence of glucose differs from that of strains BL153 (lacE) and BL155 (lacF) (Fig. 3). This might be due to the 
fact that the latest strains contain a functional PTS for glucose uptake while strain BL126 (ptsI) can only transport 
this sugar by the proton-driven permease34.
LacG is involved in the metabolism of LacNAc and lactose. To determine if the phospho-β-galactosidase 
LacG was involved in the utilization of LacNAc in L. casei BL23, a mutant in lacG was constructed (strain BL400). 
This mutant was cultured in sugar-free MRS supplemented with 4 mM LacNAc as carbon source (Fig. 4). The growth 
pattern showed that BL400 (lacG) strain did not ferment LacNAc and neither did lactose, the only substrate described 
until now for the lac operon26–28. These results indicated that LacG is necessary for the utilization of both disaccharides 
(Fig. 1b). Sugar content analysis of the culture supernatants detected LacNAc and lactose, respectively, in the superna-
tants from BL400 (lacG), while they were completely consumed by the wild-type BL23 strain (data not shown).
LacG (EC 3.2.1.85) belongs to the glycosyl hydrolase family 1 (GH 1; www.cazy.org), which includes 
β-glycosidases as well as phospho-β-glycosidases. In order to characterize that enzyme, the lacG gene was 
expressed in E. coli as a His-tagged protein and purified to homogeneity (data not shown). The purified pro-
tein displayed a molecular weight of 55 kDa, in agreement with the calculated mass of the 6x(His)-tagged pro-
tein (55,305 Da). 6x(His)LacG did not hydrolyze o-NP-β-D-galactopyranoside but it does when this substrate is 
phosphorylated (Table 1), suggesting a high selectivity toward phosphorylated compounds. The kinetic analysis 
showed a high Km and low Vmax for o-NP-β-D-galactopyranoside-6P, and it displayed an optimal pH of 7.0 and 
an optimal temperature of 41 °C (Table 1). 6x(His)LacG was unable to hydrolyze any of the natural oligosaccha-
rides tested (Table 1), including lactose and LacNAc, possibly because these need to be phosphorylated before 
turned into substrates for this glycosidase.
The tagatose-6P pathway and the N-acetylglucosamine-6P deacetylase NagA are involved 
in the metabolism of LacNAc. The results described above suggest that, as occurs with lactose, LacNAc 
is transported and phosphorylated by the PTSLac, and then hydrolyzed by the phospho-β-galactosidase 
LacG into GlcNAc and Gal-6P. It has been assumed that this phosphorylated sugar resulting from the lac-
tose metabolism is catabolized through the Tag-6P pathway in L. casei35,36. To analyze this at the genetic 
level, the mutant strain L. casei BL393 (lacAB), deficient in the heteromeric Gal-6P isomerase of the 
Tag-6P route24, was cultured on lactose or LacNAc (Fig. 5). This strain showed a growth rate in lactose 
Figure 2. Growth curves of Lactobacillus casei wild type strain BL23 on sugar-free MRS without carbon source 
(black), with N-acetyllactosamine (LacNAc) (red), lactose (blue) or glucose (green). Data presented are mean 
values based on at least three replicates. Error bars indicate standard deviations.
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(0.0293 ± 0.0014 h−1) and LacNAc (0.0307 ± 0.0009 h−1) significantly lower than the wild-type on these 
disaccharides (0.1010 ± 0.0006 h−1 and 0.0522 ± 0.0005 h−1, respectively) (wild-type versus lacAB mutant, 
P = 0.0004 (lactose); P = 0.0012 (LacNAc)). These results supported that lactose and LacNAc metabolism 
in L. casei utilizes the Tag-6P pathway for the catabolism of the galactose moiety (Fig. 1b). Additionally, 
Figure 3. Growth curves of Lactobacillus casei mutant strain BL385 (gnbG) (a) on sugar-free MRS without 
carbon source (black) or with N-acetyllactosamine (LacNAc) (red). Data presented are mean values based on 
at least three replicates. Error bars indicate standard deviations. Growth curves of L. casei mutant strain BL153 
(lacE) (b), L. casei mutant strain BL155 (lacF) (c) and L. casei mutant strain BL126 (pstI) (d) on sugar-free MRS 
without carbon source (black), with N-acetyllactosamine (LacNAc) (red), glucose (green) or lactose (blue). Data 
presented are mean values based on at least three replicates. Error bars indicate standard deviations.
Figure 4. Growth curves of Lactobacillus casei mutant strain BL400 (lacG) on sugar-free MRS without carbon 
source (black), with N-acetyllactosamine (LacNAc) (red), glucose (green) or lactose (blue). Data presented are 
mean values based on at least three replicates. Error bars indicate standard deviations.
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these results suggest that the residual growth showed by BL393 (lacAB) strain on those carbohydrates would 
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Lacto-N-tetraose (Galβ1-3GlcNAcβ1-3 Galβ1-4Glc) −











Vmax (μmol (mg protein−1 min−1) 1.4
Km (mM) 3.0
Optimal pH 7.0
Optimal temperature (°C) 41
Table 1. Activity and characterization of the phospho-β-galactosidase LacG. aCarbohydrates used as substrates. 
NP, nitrophenyl; Glc, glucose; Gal, Galactose; GlcNAc, N-acetylglucosamine; GalNAc, N-acetylgalactosamine; 
Man, mannose; Fru, fructose. b+, substrate is totally hydrolyzed after 16 h reaction in the conditions described 
in the “Materials and methods” section; −, no activity detected. cThe enzyme activity was determined with o-
nitrophenyl-β-D-galactopyranoside-6-P as the substrate.
Figure 5. Growth curves of Lactobacillus casei wild type strain BL23 (blue) and mutant strain BL393 (lacAB) 
(cyan) on sugar-free MRS with lactose. BL23 (red) and mutants BL393 (lacAB) (pink) and BL388 (nagA) 
(green) on sugar-free MRS supplemented with N-acetyllactosamine (LacNAc). Data presented are mean values 
based on at least three replicates. Error bars indicate standard deviations.
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We have previously shown that in L. casei the nagA gene, encoding an N-acetylglucosamine-6P deacetylase, is 
involved in the metabolism of GlcNAc either free o derived from LNB24. Here, we tested the growth of the mutant 
strain L. casei BL388 disrupted in nagA on LacNAc as carbon source (Fig. 5). The results showed a growth rate 
for this mutant (0.0436 ± 0.0008 h−1) significantly lower (P = 0.004) than the wild-type (0.0522 ± 0.0005 h−1), 
suggesting that nagA is required for the catabolism of the GlcNAc moiety resulting from the hydrolysis of this 
disaccharide.
Transcriptional analyses of the lac operon. Northern blot analyses have previously shown that the 
lacTEGF operon from L. casei is induced by lactose and subjected to carbon catabolite repression by glucose28. In 
order to determine if the transcription of the lac genes are also regulated by LacNAc, RNA was isolated from L. 
casei wild-type strain BL23 grown in sugar-free MRS containing galactose, GlcNAc, glucose, LacNAc or LacNAc 
plus glucose and used for RT-qPCR analyses. Additionally, RNA obtained from cultures grown on lactose or 
lactose plus glucose were also included in these analyses to quantify the expression levels of the lac genes in these 
carbon sources (Fig. 6). Taking as a reference the transcript levels in cells growing in glucose, the lacT, lacE, lacG 
and lacF were induced by LacNAc and lactose. The induction levels ranged from 130 to 320–fold and from 100 
to 200–fold in LacNAc and lactose, respectively. The expression levels were highly reduced when these carbohy-
drates were mixed with glucose (Fig. 6). These results indicate that the lac operon in addition to lactose is also 
induced by LacNAc and confirmed that it is repressed by glucose. The lac genes were barely expressed in the pres-
ence of galactose and GlcNAc, denoting that their induction relies on the presence of the disaccharide and not on 
the monosaccharides resulting from the hydrolysis.
The transcriptional antiterminator LacT is required for LacNAc metabolism. The L. casei LacT 
protein prevents transcription termination of the lac operon in response to the presence of lactose in the culture 
medium26. In order to determine the involvement of this transcriptional antiterminator in the metabolism of 
LacNAc, the mutant strain L. casei BL195 (lacT), deficient in LacT26, was cultured on LacNAc as carbon source 
(Fig. 7). BL195 (lacT) strain was also grown with glucose and lactose as positive and negative controls, respec-
tively. The results show that this mutant strain exhibited a growth in the presence of LacNAc similar to that of 
the negative controls (lactose supplemented and non-supplemented sugar-free MRS), indicating that the tran-
scriptional antitermiator LacT is also involved on LacNAc metabolism. Additionally, the results suggest that 
LacT antiterminates transcription of lac operon not only depending on the presence of lactose if not also on the 
presence of LacNAc in the growth medium.
Discussion
The disaccharide N-acetyllactosamine (LacNac) has an important role in many cell recognition processes such 
as parasite-host cell interaction37, autoimmune38 and inflammatory39 diseases, and also in cancer40. Additionally, 
LacNAc is a key structure present at human milk oligosaccharides and also at the glycan domains of glycoproteins 
and glycolipids present in the gastrointestinal tract41–43. We have demonstrated that L. casei is able to metabolize 
LacNAc. Curiously, the lac operon, which has been widely studied in this strain26–28, is also the responsible of the 
transport and catabolism of LacNAc. As previously described for the PTSGnb, that is involved in the transport 
of N-acetyl-galactosamine, LNB and GNB in L. casei24, the PTSLac represents a new example of a PTS able to 
transport two structurally related substrates, lactose and LacNAc. L. casei mutants deficient in either EIICBLac 
or EIIALac 28, were unable to grow in the presence of LacNAc. Due to the great biotechnological and economic 
Figure 6. Transcriptional analysis by RT-qPCR of the expression of lacT (blue bars), lacE (green bars), lacG 
(black bars) and lacF (red bars) in Lactobacillus casei wild type strain BL23 grown in sugar-free MRS containing 
galactose (Gal), N-acetylglucosamine (GlcNAc), N-acetyllactosamine (LacNAc), lactose (Lac), a mix of glucose 
and lactose (Glc + Lac) or a mix of glucose and N-acetyllactosamine (Glc + LacNAc). Cells grown in sugar-free 
MRS supplemented with glucose were used as reference condition. Data presented are mean values based on 
three replicates of at least two biological independent samples. Bars indicate standard errors. For each lac gene, 
significantly different values (P < 0.05) among culture conditions are marked by different lower-case letters.
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importance of lactose fermentation in the dairy industry there are a great number of studies directed to analyze 
lactose fermentation by lactic acid bacteria44–47. Lactose in these bacteria can be transported through proton 
symport permeases, lactose/galactose antiport systems44,48 or via PTS28,49–51. Analysis of the genome sequence of 
lactobacilli (http://www.ncbi.nlm.nih.gov/genomes) showed that genes encoding PTSs homologous to the PTSLac 
from L. casei BL23, are present in the Lactobacillus casei/paracasei/rhamnosus/zeae group of phylogenetically 
related lactobacilli, and also in a few strains of Lactobacillus heilongjiangensis, Lactobacillus futsaii, Lactobacillus 
farciminis, Lactobacillus perolens, Lactobacillus fermentum, Lactobacillus sharpeae, Lactobacillus crustorum, 
Lactobacillus pobuzihii, Lactobacillus kimchiensis, Lactobacillus ruminis, Lactobacillus gasseri and Lactobacillus 
johnsonii, suggesting that lactose-specific PTSs are widely distributed among lactobacilli. For L. gasseri strain 
ATCC 33323, which is autochthonous of the gut, it has already been demonstrated that it contains two different 
PTSs involved in the transport of lactose and that the expression of both was induced by this carbohydrate51. 
Another strain indigenous of the gut is L. rhamnosous TCELL-1, for which it has also been demonstrated that 
the lac operon is induced by lactose50. Whether those PTS are functional for lactose and LacNAc remains to be 
investigated. Transcriptional analysis demonstrated here that the lac operon from L. casei is induced by lactose 
as well as by LacNAc and that induction levels are higher on LacNAc than on lactose. This might suggest that 
LacNAc is the substrate to which the lac operon had been adapted first. Indeed, many L. casei strains have been 
isolated from the human gastrointestinal tract52,53, which is very rich in LacNAc5,41. In E. coli, the lac operon is not 
regulated directly by lactose if not by allolactose, a transient product synthesized by the β-galactosidase, and this 
has generated controversy about the true physiological role of the lac operon in this bacterium54.
L. casei transport LacNAc or lactose through the PTSLac resulting in the formation of LacNAc-P or lactose-P, 
which are further hydrolyzed inside the cell by the phospho-β-galactosidase LacG into Gal-6P and GlcNAc or 
glucose, respectively (Fig. 1b). We have biochemically characterized this enzyme and confirmed that can only 
hydrolyze phosphorylated substrates. This also occurs with all the proteins homologs to LacG that have been char-
acterized until now, which have been isolated from Streptococcus mutants55, Saphylococcus aureus, Lactococcus 
lactis, L. casei strain 64H56 and L. gasseri57. Contrarily, β-galactosidases isolated from Bifidobacterium bifidum are 
able to hydrolyze non-phosphorylated lactose and LacNAc11,12, showing two different mechanisms to metabolize 
these disaccharides in species that would compete for them in environmental niches such as the gastrointestinal 
tract. The Gal-6P generated after the hydrolysis of LacNAc-P or lactose-P by LacG is channeled through the 
Tag-6P pathway. We have showed that the mutant strain L. casei BL393 (lacAB) is impaired in the growth on lac-
tose and LacNAc. The genes encoding the Tag-6P route in L. casei are present in the operon lacR1ABD2C, which 
includes a transcriptional regulator LacR1, the two subunits of the heteromeric Gal-6P isomerase (lacAB), a 
Tag-6P kinase (lacC) and a Tag-1,6-bisP aldolase (lacD2). Unlike L. casei, in Lactococcus lactis58 and Streptococcus 
mutans59, the lac operon contains the genes lacRABCDFEG encoding the Tag-6P catabolic proteins in addition to 
the lactose-specific PTS and the phospho-β-galactosidase LacG.
L. casei species have been isolated from dairy products, plant material and reproductive and gastrointestinal 
tracts of humans and animals52,53, which reveals their great adaptability to different environments. Genome anal-
yses have showed that gene loss and acquisition are the main events resulting in niche adaptation60. Additionally, 
lactobacilli also contain genes involved in sugar uptake, metabolism and regulation grouped in genomic islands61. 
Lactose metabolism is well known in the dairy industry, but few data is found about its metabolism by the gas-
trointestinal microbiota. Lactose and LacNAc are constituents of HMO molecules that reach the breastfeeding 
infant gut microbiota, and LacNAc and poly-LacNAc molecules are also present in high amounts in the newborn 
gut62,63. Here we showed that L. casei metabolizes both disaccharides by using the same transport system and 
catabolic enzymes, which could be another niche adaptation mechanism of this bacterium to optimize the meta-
bolic machinery minimizing energy consumption in a very competitive environment such as the gastrointestinal 
tract. Furthermore, the present work evidences that a catabolic pathway designed for survival of lactobacilli in the 
children gut has become an important tool for the development of dairy fermented products.
Figure 7. Growth curves of Lactobacillus casei mutant strain BL195 (lacT) on sugar-free MRS without carbon 
source (black), with N-acetyllactosamine (LacNAc) (red), glucose (green) or lactose (blue). Data presented are 
mean values based on at least three replicates. Error bars indicate standard deviations.
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Materials and Methods
Strains, growth conditions and plasmids. The strains and plasmids used in this work are enumerated 
in Table 2. The L. casei strains were grown at 37 °C in MRS broth (Difco). E. coli was utilized as a cloning host 
and was grown in Luria-Bertani medium (Pronadisa) at 37 °C. E. coli DH10B transformants were selected with 
ampicillin (100 μg ml−1), E. coli BE50 with ampicillin (100 μg ml−1) and kanamycin (25 μg ml−1) and L. casei with 
erythromycin (5 μg ml−1). The vectors pRV30064 and pQE80 (Qiagen) were used for disruption of genes in L. 
casei and overproduction of proteins, respectively. E. coli strains were transformed by electroporation with a Gene 
Pulser apparatus (Bio-Rad Laboratories) as indicated by the manufacturer, and L. casei strains were transformed 
as described previously65.
Culture of L. casei strains with lactose and LacNAc. The L. casei strains were cultured as previously 
described24 on sugar-free MRS containing: bactopeptone (Difco), 10 g l−1; yeast extract (Pronadisa), 4 g l−1; 
sodium acetate, 5 g l−1; tri-ammonium citrate, 2 g l−1; magnesium sulphate 7-hydrate, 0.2 g l−1; manganese sul-
phate monohydrate, 0.05 g l−1; and Tween 80, 1 ml l−1. LacNAc (Carbosynth, Compton, Berkshire, UK), lactose 
(Sigma-Aldrich, St. Louis, MO, USA), N-acetylglucosamine, galactose or glucose were added to the sugar-free 
MRS medium at a concentration of 4 mM. Bacterial growth was assayed in microtiter plates (100 μl culture broth 
per well) at 37 °C in a POLARstar Omega plate reader (BMG Labtech, Offenburg, Germany). The Gompertz 
model (GraphPad Software, San Diego, CA) was used for the analysis of the growth rates (μ).
DNA manipulation and sequencing. DNA was obtained from L. casei BL23 as previously described65. Plasmid 
DNA was isolated from E. coli by using the kit illustra plasmidPrep Mini Spin (GE Healthcare, UK). Standard methods 
were used for recombinant DNA techniques66 and PCR reactions were carried out with the Expand High Fidelity PCR 
System (Roche). The DNA sequencing reactions were performed by the Central Service of Research Support of the 
University of Valencia (Spain). Specific primers hybridizing within the proper DNA fragments and universal primers 
were used for sequencing. The analysis of DNA sequences was performed with the aid of the DNAMAN 4.03 software 
package (Lynnon BioSoft) and sequence similarities were analyzed with the BLAST program67.
Construction of a lacG mutant strain. A DNA fragment containing part of lacG was obtained by PCR 
using L. casei BL23 chromosomal DNA and the oligonucleotides lacGfor (5′-CAAGGAAGACGGTAAAGG) and 
lacGrev (5′-CCAACGGATAGTCATTATG). The PCR product was cloned into pRV300 digested with EcoRV. The 
resulting plasmid pRVlacG was cleaved at the unique SphI restriction site, made blunt with the Klenow fragment, 
ligated and transformed to select a plasmid with a frameshift at the SphI site in lacG. L. casei was transformed 
with this plasmid and one integrant where single recombination occurred was selected and cultured at 37 °C 
without antibiotic selection for at least 200 generations. Cells were grown on MRS-agar plates and screened for 
erythromycin-sensitive phenotype by replica plating on MRS-agar plates with erythromycin. Antibiotic-sensitive 
clones were selected and, among them, one was chosen (BL400 strain) in which a double-crossover event con-
ducted to the excision of the plasmid resulting in a mutated lacG copy, as was confirmed by sequencing of 
PCR-amplified fragment spanning the mutated region.
Strain or plasmid Relevant genotype or properties Source or reference
Strains
Lactobacillus casei
BL23 Wild type CECT 5275 (Acedo-Félix et al.70)
BL126 BL23 ptsI Viana et al.33
BL153 BL23 lacE Gosalbes et al.28
BL155 BL23 lacF Gosalbes et al.28
BL195 BL23 lacT Gosalbes et al.26
BL385 BL23 gnbC::pRV300 ErmR Bidart et al.24
BL388 BL23 nagA::pRV300 ErmR Bidart et al.24
BL393 BL23 lacAB Bidart et al.24
BL400 BL23 lacG (frameshift at SphI site) This work
Escherichia coli
DH10B F
− endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 
araD139 Δ(ara,leu)7697 mcrA Δ(mrr) sdRMS-mcrBC) λ− Invitrogen
BE50 BL21(DE3) containing pREPGroES/GroEL Dale et al.71
PE172 BE50 containing pQElacG This work
Plasmids
pRV300 Suicide vector carrying ErmR from pAMβ1 Leloup et al.64
pRVlacG pRV300 with a frameshift at SphI site in lacG fragment This work
pQE80 E. coli expression vector; AmpR Qiagen
pQElacG pQE80 containing lacG-coding region This work
Table 2. Strains and plasmids used in this studya. aCECT, Colección Española de Cultivos Tipo; ErmR, 
erythromycin resistance; AmpR, ampicillin resistant.
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Disaccharide and monosaccharide analysis in culture supernatants. The cells from the L. casei cul-
tures were eliminated by centrifugation and the supernatants were collected for sugar determination. The analyses 
were carried out by high-performance liquid chromatography (HPLC) with a Jasco PU2080Plus system. A Rezex 
RCM-Monosaccharide column (Phenomenex) (at 80 °C) was used and the samples elution was performed in iso-
cratic mode using a flow rate of 0.6 ml min−1. The mobile phase was water and a refractive index detector (Jasco 
RI-2031 Plus) was used for carbohydrate detection. Peaks in the chromatograms were identified by comparing the 
retention times with those of the standards (LacNAc, lactose, glucose, galactose and GlcNAc).
Expression and purification of His-tagged LacG. lacG coding region was amplified by PCR using genomic 
DNA of wild-type L. casei strain BL23 as template and the primers LacGBamHIFW (5′-TTTTGGATCCATGAGT 
AAACAGCTACCTCAAG) and LacGPstIRV (5′-TTTTCTGCAGTTAATCCGGAATGATGTGGG) with added 
BamHI and PstI restriction sites to the 5′- and 3′-ends (underlined). The obtained PCR product was digested 
with BamHI and PstI, cloned into pQE80 and the resulting plasmid pQElacG was used to transform E. coli BE50. 
DNA sequencing was carried out to confirm the correct construction. One clone, PE172 (pQElacG) was selected, 
grown in Luria-Bertani medium and induced with IPTG (1 mM) as described before25. The recombinant protein 
was purified and analyzed as described previously24.
His-tagged LacG enzyme activity. 100 μl reaction mixtures containing different o/p-nitrophenyl(N-
P)-sugars (Table 1) at 5 mM were performed in 96-well microtiter plates. The LacG activity was measured at 
37 °C in 100 mM Tris-HCl buffer, pH 7.0, and the reaction started by adding 1 μg of enzyme. The amount of 
released o/p-nitrophenol was tested by tracking the absorbance change with time at 404 nm using a microplate 
reader (POLARstar Omega, BMG Labtech, Offenburg, Germany). The optimal pH and temperature reaction, 
and kinetic analysis were determined with o-NP-β-D-galactopyranoside-6-phosphate as previously described24.
LacG was tested for its capacity to hydrolyse different natural oligosaccharides (Table 1). 100 μl reactions 
containing substrate (4 mM) in 100 mM Tris-HCl buffer, pH7.0 were performed at 37 °C for 16 h. The reac-
tion mixtures were analysed by HPLC as described above. Peaks in the chromatograms were identified by 
comparing the retention times with those of the standards (LNB, GNB, lacto-N-tetraose, lacto-N-neotetraose, 
3′-N-acetilgalactosaminil-Gal, 3′-N-acetilglucosaminil-Man, 4′-galactofuranosil-GlcNAc, fucosyl-α1–3GlcNAc, 
LacNAc, lactose, lactulose, maltose, maltotriose, glucose, galactose, GlcNAc, mannose, GalNAc, L-fucose and 
fructose). All the oligo- and disaccharides were obtained from Carbosynth (Compton, Berkshire, UK), except 
lactose, lactulose, maltose and maltotriose that were obtained from Sigma-Aldrich (St. Louis, MO, USA).
RNA isolation and Reverse Transcriptase quantitative PCR (RT-qPCR). Total RNA was iso-
lated from L. casei strain BL23 grown in sugar-free MRS supplemented with 4 mM of different sugars as pre-
viously described24. Cells were harvested at mid-exponential phase of growth (OD550 of 0.3 for cultures on 
glucose, galactose or GlcNAc and 0.5 for cultures on LacNAc, lactose, a mix of LacNAc plus glucose or lac-
tose plus glucose). The isolated RNA was digested with DNaseI and retro-transcribed using the Maxima First 
strand cDNA Synthesis Kit (Fermentas)24. The resulted cDNA was subjected to quantitative PCR for the genes 
lacT, lacE, lacG and lacF. RT-qPCR was performed using the Lightcycler 2.0 system (Roche), LC Fast Start 
DNA Master SYBR green I (Roche) and primers pairs that produce amplicons ranging from 70 to 200 bp in 
size. RT-qPCR was performed for each cDNA sample in triplicate and using the primers pairs: qPCRlacTfor 
(5′-TTGTAAGGGGACGTGGCATC)/qPCRlacTrev (5′-TTGTCGGGAAGTCTCGTTCG) (lacT), qPCRlacE-
for (5′-TTGGCCATGAACACGATGGA)/qPCRlacErev (5′-CCGAAAGTGCATGGCACAAA) (lacE), qPCR-
lacGfor (5′-AAGTCGAAGGAGCCACCAAG)/qPCRlacGrev (5′-GAACCGCCCCTGTTTATCCA) (lacG) and 
qPCRlacFfor (5′-GGTTTTGCACTTGTGGCGTA)/qPCRlacFrev (5′-CTGTTGGGCCTTCTCAACCA) (lacF). 
The reaction mixtures and cycling conditions were performed as previously described24. The pyrG, lepA and IleS 
genes were chosen as reference genes68. Cells growing in sugar-free MRS supplemented with glucose were used 
as reference condition. The relative expression based on the expression ratio between the target genes and refer-
ence genes was calculated using the software tool REST (relative expression software tool)69. The efficiency of all 
the primer pairs was between 1.9 and 2 (close to 100%). RT-qPCR reactions were performed in triplicate of two 
biological independent samples.
Statistical analysis. Statistical analysis was performed using the Statgraphics Plus, ver. 2.1 (Statistical 
Graphics Corp., USA). One way analysis of variance (ANOVA) was used to assess the effects of the carbon source 
(galactose, GlcNAc, LacNAc, lactose, a mix of glucose and lactose, and a mix of glucose and LacNAc) on the 
expression levels of the lac genes. Student’s t-test was used to detect statistically significant differences between 
growth rate from L. casei wild-type BL23 strain versus each mutant BL393 (lacAB) and BL388 (nagA) strains. 
Statistical significance was accepted at P < 0.05.
Data availability statement. All data generated or analyzed during this study are included in this pub-
lished article.
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